Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W C Jackson

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of the American Board of Family Practice|October 26, 1999
Professional identity and namesW C Jackson
JAMA|August 26, 1998
A piece of my mind. In a wordW C Jackson
Group Practice Journal|October 8, 1980
Marketing research in a competitive health care environmentD J Cunningham, W C Jackson
Archives of Family Medicine|July 26, 2000
Amylophagia presenting as gestational diabetesW C Jackson, J P Martin
Applied and Environmental Microbiology|September 1, 1994
Differential Effect of Tetrazolium Dyes upon Bacteriophage Plaque Assay TitersC J Hurst, J C Blannon, R L Hardaway, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2020
Response to Kibe Y et al. "Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)"W C Jackson, K C Cuneo, T S Lawrence, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapyW C Jackson, K Suresh, C Maurino, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
Prostate Cancer and Prostatic Diseases|May 25, 2016
Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-upD E Spratt, W C Jackson, A Abugharib, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of the American Board of Family Practice|October 26, 1999
Professional identity and namesW C Jackson
JAMA|August 26, 1998
A piece of my mind. In a wordW C Jackson
Group Practice Journal|October 8, 1980
Marketing research in a competitive health care environmentD J Cunningham, W C Jackson
Archives of Family Medicine|July 26, 2000
Amylophagia presenting as gestational diabetesW C Jackson, J P Martin
Applied and Environmental Microbiology|September 1, 1994
Differential Effect of Tetrazolium Dyes upon Bacteriophage Plaque Assay TitersC J Hurst, J C Blannon, R L Hardaway, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 8, 2020
Response to Kibe Y et al. "Methodological concerns for investigating the effects of midtreatment break of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma (HCC)"W C Jackson, K C Cuneo, T S Lawrence, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 22, 2019
A mid-treatment break and reassessment maintains tumor control and reduces toxicity in patients with hepatocellular carcinoma treated with stereotactic body radiation therapyW C Jackson, K Suresh, C Maurino, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
Prostate Cancer and Prostatic Diseases|May 25, 2016
Independent validation of the prognostic capacity of the ISUP prostate cancer grade grouping system for radiation treated patients with long-term follow-upD E Spratt, W C Jackson, A Abugharib, et al.
Journal of Internal Medicine|January 18, 2021
Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer's disease (MCI and dementia) in primary care: a review and synthesisJ L Liss, S Seleri Assunção, J Cummings, et al.
Pageof 1